Vir Biotechnology, Inc.·4

Feb 21, 7:25 PM ET

Rice Steven J. 4

4 · Vir Biotechnology, Inc. · Filed Feb 21, 2023

Insider Transaction Report

Form 4
Period: 2023-02-17
Rice Steven J.
Chief Administrative Officer
Transactions
  • Sale

    Common Stock

    2023-02-17$25.29/sh1,981$50,09637,209 total
Footnotes (2)
  • [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
  • [F2]Includes 532 shares of common stock acquired by the reporting person on May 31, 2022 pursuant to an employee stock purchase program.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION